[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100338225":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":24,"centralContacts":29,"locations":34,"responsibleParty":50,"collaborators":52,"id":56,"slug":20,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":20,"eligibilityCriteria":60,"healthyVolunteers":57,"sex":61,"minAge":62,"maxAge":20,"enrollmentInfo":63,"targetDuration":20,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":72,"overallStatus":36,"whyStopped":20,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Dana-Farber Cancer Institute","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"MRiS","EXPERIMENTAL","* The specimens to be collected will include at least five pleural biopsy samples\n* MPT test and the CLDN15\u002FVIM test will be performed",[13,14],"Other: MPT Test","Other: CLDN15\u002FVIM Test",[16,21],{"type":6,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"MPT Test","molecular expression tests at the RNA level using approximately 7 or more genes with RTPCR, nanostring or similar platforms",[9],null,{"type":6,"name":22,"description":18,"armGroupLabels":23,"otherNames":20},"CLDN15\u002FVIM Test",[9],[25],{"name":26,"affiliation":27,"role":28},"Raphael Bueno, MD","Brigham and Women's Hospital","PRINCIPAL_INVESTIGATOR",[30],{"name":26,"role":31,"phone":32,"phoneExt":20,"email":33},"CONTACT","617-732-5690","rbueno@partners.org",[35],{"facility":27,"status":36,"city":37,"state":38,"zip":39,"country":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"RECRUITING","Boston","Massachusetts","02215","United States",{"type":42,"coordinates":43},"Point",[44,45],-71.05977,42.35843,{"lat":45,"lon":44},[48,49],{"name":26,"role":31,"phone":32,"phoneExt":20,"email":33},{"name":26,"role":28,"phone":20,"phoneExt":20,"email":20},{"type":28,"investigatorFullName":26,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"Principal Investigator",[53],{"name":54,"class":55},"National Cancer Institute (NCI)","NIH","100338225",false,"NCT03683680","Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers","Inclusion Criteria:\n\n* All adult patients with a diagnosis of malignant pleural mesothelioma undergoing\n\n  * diagnostic pleural biopsy\n  * pleuroscopy\n  * and\u002For VATS resections\n* Participants must be 18 years of age or older.\n\nExclusion Criteria:\n\n-Any patient who is found to be unsuitable for\n\n* surgery,\n* treatment\n* diagnosis,","ALL","18 Years",{"count":64,"type":65},240,"ESTIMATED","INTERVENTIONAL",[68],"NA","This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma.",[71],"Mesothelioma",[71],"2026-04-29",{"date":75,"type":76},"2026-05-05","ACTUAL",{"date":78,"type":76},"2018-10-31",{"date":80,"type":65},"2030-10-01",{"name":5,"class":6},1]